Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 7Interventional 2

Sponsor

Cancer Type

Genitourinary 2Gastrointestinal 2Sarcoma 1Other hematologic neoplasm 1CNS 1Breast 1

Conditions

Prostatic Neoplasms 1Kidney Neoplasms 1Disease 1

Interventions

Docetaxel 390pembrolizumab 325Prednisone 284Gemcitabine 273enzalutamide 254Radiotherapy 251Nivolumab 247Magnetic Resonance Spectroscopy 247Cisplatin 209Abiraterone Acetate 197Radiosurgery 184Leuprolide 182Sunitinib 169Carboplatin 161bicalutamide 148Goserelin 145Androgen Antagonists 142Specimen Handling 138Ipilimumab 128Paclitaxel 125Cyclophosphamide 116acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 110Bevacizumab 109Everolimus 107apalutamide 98cabozantinib 97abiraterone 97Sorafenib 97atezolizumab 96Radiation 89

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Urination × Genitourinary × Clear all
NCT03730324 2023-03-23

ProBioM

Odense University Hospital

Phase NA Completed
261 enrolled
Genitourinary

Disease, Prostatic Neoplasms

NCT04005820 2019-07-02

UMBRELLA

Assistance Publique Hopitaux De Marseille

Phase NA Not yet recruiting
510 enrolled
Genitourinary

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡